1. Novo Nordisk
2. Sanofi
3. Merck & Co.
4. AstraZeneca
5. Eli Lilly and Company
6. Johnson & Johnson
7. Boehringer Ingelheim
8. Abbott Laboratories
9. Bristol-Myers Squibb
10. GlaxoSmithKline
The Antidiabetics Market is highly competitive with key players such as Novo Nordisk, Sanofi, and Merck & Co. dominating the global landscape. These companies are continuously innovating and expanding their product portfolios to cater to the growing diabetic population worldwide. Other notable players include AstraZeneca, Eli Lilly and Company, and Johnson & Johnson, who also contribute significantly to the market. The competition in the Antidiabetics Market is intense, with companies vying for market share through strategic partnerships, mergers, and acquisitions.